Medical Care
Global Novel Vaccine Delivery Systems Market Research Report 2024
- Aug 28, 24
- ID: 515302
- Pages: 88
- Figures: 166
- Views: 1
Novel vaccine delivery includes formulations, technologies, methods, and systems to transfer an active pharmaceutical ingredient in the body, as desired, in order to safely accomplish its therapeutic effect.
The global Novel Vaccine Delivery Systems market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Novel Vaccine Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Novel Vaccine Delivery Systems.
Report Scope
The Novel Vaccine Delivery Systems market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Novel Vaccine Delivery Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Novel Vaccine Delivery Systems companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Altaris Capital Partners
Kindeva Drug Delivery
Becton
Dickinson,
Carl Zeiss Foundation
Gerresheimer AG
Corium International
Inovio Pharmaceuticals
Bioject Medical Technologies
PharmaJet
Retractable Technologies
Terumo Corporation
VAXXAS
Segment by Type
Intramuscular Delivery
Intramuscular Delivery
Others
Segment by Application
Hospitals & Clinics
Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Novel Vaccine Delivery Systems companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Novel Vaccine Delivery Systems market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Novel Vaccine Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Novel Vaccine Delivery Systems.
Report Scope
The Novel Vaccine Delivery Systems market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Novel Vaccine Delivery Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Novel Vaccine Delivery Systems companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Altaris Capital Partners
Kindeva Drug Delivery
Becton
Dickinson,
Carl Zeiss Foundation
Gerresheimer AG
Corium International
Inovio Pharmaceuticals
Bioject Medical Technologies
PharmaJet
Retractable Technologies
Terumo Corporation
VAXXAS
Segment by Type
Intramuscular Delivery
Intramuscular Delivery
Others
Segment by Application
Hospitals & Clinics
Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Novel Vaccine Delivery Systems companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Novel Vaccine Delivery Systems Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Intramuscular Delivery
1.2.3 Intramuscular Delivery
1.2.4 Others
1.3 Market by Application
1.3.1 Global Novel Vaccine Delivery Systems Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals & Clinics
1.3.3 Research Institutes
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Novel Vaccine Delivery Systems Market Perspective (2019-2030)
2.2 Novel Vaccine Delivery Systems Growth Trends by Region
2.2.1 Global Novel Vaccine Delivery Systems Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Novel Vaccine Delivery Systems Historic Market Size by Region (2019-2024)
2.2.3 Novel Vaccine Delivery Systems Forecasted Market Size by Region (2025-2030)
2.3 Novel Vaccine Delivery Systems Market Dynamics
2.3.1 Novel Vaccine Delivery Systems Industry Trends
2.3.2 Novel Vaccine Delivery Systems Market Drivers
2.3.3 Novel Vaccine Delivery Systems Market Challenges
2.3.4 Novel Vaccine Delivery Systems Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Novel Vaccine Delivery Systems Players by Revenue
3.1.1 Global Top Novel Vaccine Delivery Systems Players by Revenue (2019-2024)
3.1.2 Global Novel Vaccine Delivery Systems Revenue Market Share by Players (2019-2024)
3.2 Global Novel Vaccine Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Novel Vaccine Delivery Systems Revenue
3.4 Global Novel Vaccine Delivery Systems Market Concentration Ratio
3.4.1 Global Novel Vaccine Delivery Systems Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Novel Vaccine Delivery Systems Revenue in 2023
3.5 Novel Vaccine Delivery Systems Key Players Head office and Area Served
3.6 Key Players Novel Vaccine Delivery Systems Product Solution and Service
3.7 Date of Enter into Novel Vaccine Delivery Systems Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Novel Vaccine Delivery Systems Breakdown Data by Type
4.1 Global Novel Vaccine Delivery Systems Historic Market Size by Type (2019-2024)
4.2 Global Novel Vaccine Delivery Systems Forecasted Market Size by Type (2025-2030)
5 Novel Vaccine Delivery Systems Breakdown Data by Application
5.1 Global Novel Vaccine Delivery Systems Historic Market Size by Application (2019-2024)
5.2 Global Novel Vaccine Delivery Systems Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Novel Vaccine Delivery Systems Market Size (2019-2030)
6.2 North America Novel Vaccine Delivery Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Novel Vaccine Delivery Systems Market Size by Country (2019-2024)
6.4 North America Novel Vaccine Delivery Systems Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Novel Vaccine Delivery Systems Market Size (2019-2030)
7.2 Europe Novel Vaccine Delivery Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Novel Vaccine Delivery Systems Market Size by Country (2019-2024)
7.4 Europe Novel Vaccine Delivery Systems Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Novel Vaccine Delivery Systems Market Size (2019-2030)
8.2 Asia-Pacific Novel Vaccine Delivery Systems Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Novel Vaccine Delivery Systems Market Size by Region (2019-2024)
8.4 Asia-Pacific Novel Vaccine Delivery Systems Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Novel Vaccine Delivery Systems Market Size (2019-2030)
9.2 Latin America Novel Vaccine Delivery Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Novel Vaccine Delivery Systems Market Size by Country (2019-2024)
9.4 Latin America Novel Vaccine Delivery Systems Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Novel Vaccine Delivery Systems Market Size (2019-2030)
10.2 Middle East & Africa Novel Vaccine Delivery Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Novel Vaccine Delivery Systems Market Size by Country (2019-2024)
10.4 Middle East & Africa Novel Vaccine Delivery Systems Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Altaris Capital Partners
11.1.1 Altaris Capital Partners Company Detail
11.1.2 Altaris Capital Partners Business Overview
11.1.3 Altaris Capital Partners Novel Vaccine Delivery Systems Introduction
11.1.4 Altaris Capital Partners Revenue in Novel Vaccine Delivery Systems Business (2019-2024)
11.1.5 Altaris Capital Partners Recent Development
11.2 Kindeva Drug Delivery
11.2.1 Kindeva Drug Delivery Company Detail
11.2.2 Kindeva Drug Delivery Business Overview
11.2.3 Kindeva Drug Delivery Novel Vaccine Delivery Systems Introduction
11.2.4 Kindeva Drug Delivery Revenue in Novel Vaccine Delivery Systems Business (2019-2024)
11.2.5 Kindeva Drug Delivery Recent Development
11.3 Becton
11.3.1 Becton Company Detail
11.3.2 Becton Business Overview
11.3.3 Becton Novel Vaccine Delivery Systems Introduction
11.3.4 Becton Revenue in Novel Vaccine Delivery Systems Business (2019-2024)
11.3.5 Becton Recent Development
11.4 Dickinson,
11.4.1 Dickinson, Company Detail
11.4.2 Dickinson, Business Overview
11.4.3 Dickinson, Novel Vaccine Delivery Systems Introduction
11.4.4 Dickinson, Revenue in Novel Vaccine Delivery Systems Business (2019-2024)
11.4.5 Dickinson, Recent Development
11.5 Carl Zeiss Foundation
11.5.1 Carl Zeiss Foundation Company Detail
11.5.2 Carl Zeiss Foundation Business Overview
11.5.3 Carl Zeiss Foundation Novel Vaccine Delivery Systems Introduction
11.5.4 Carl Zeiss Foundation Revenue in Novel Vaccine Delivery Systems Business (2019-2024)
11.5.5 Carl Zeiss Foundation Recent Development
11.6 Gerresheimer AG
11.6.1 Gerresheimer AG Company Detail
11.6.2 Gerresheimer AG Business Overview
11.6.3 Gerresheimer AG Novel Vaccine Delivery Systems Introduction
11.6.4 Gerresheimer AG Revenue in Novel Vaccine Delivery Systems Business (2019-2024)
11.6.5 Gerresheimer AG Recent Development
11.7 Corium International
11.7.1 Corium International Company Detail
11.7.2 Corium International Business Overview
11.7.3 Corium International Novel Vaccine Delivery Systems Introduction
11.7.4 Corium International Revenue in Novel Vaccine Delivery Systems Business (2019-2024)
11.7.5 Corium International Recent Development
11.8 Inovio Pharmaceuticals
11.8.1 Inovio Pharmaceuticals Company Detail
11.8.2 Inovio Pharmaceuticals Business Overview
11.8.3 Inovio Pharmaceuticals Novel Vaccine Delivery Systems Introduction
11.8.4 Inovio Pharmaceuticals Revenue in Novel Vaccine Delivery Systems Business (2019-2024)
11.8.5 Inovio Pharmaceuticals Recent Development
11.9 Bioject Medical Technologies
11.9.1 Bioject Medical Technologies Company Detail
11.9.2 Bioject Medical Technologies Business Overview
11.9.3 Bioject Medical Technologies Novel Vaccine Delivery Systems Introduction
11.9.4 Bioject Medical Technologies Revenue in Novel Vaccine Delivery Systems Business (2019-2024)
11.9.5 Bioject Medical Technologies Recent Development
11.10 PharmaJet
11.10.1 PharmaJet Company Detail
11.10.2 PharmaJet Business Overview
11.10.3 PharmaJet Novel Vaccine Delivery Systems Introduction
11.10.4 PharmaJet Revenue in Novel Vaccine Delivery Systems Business (2019-2024)
11.10.5 PharmaJet Recent Development
11.11 Retractable Technologies
11.11.1 Retractable Technologies Company Detail
11.11.2 Retractable Technologies Business Overview
11.11.3 Retractable Technologies Novel Vaccine Delivery Systems Introduction
11.11.4 Retractable Technologies Revenue in Novel Vaccine Delivery Systems Business (2019-2024)
11.11.5 Retractable Technologies Recent Development
11.12 Terumo Corporation
11.12.1 Terumo Corporation Company Detail
11.12.2 Terumo Corporation Business Overview
11.12.3 Terumo Corporation Novel Vaccine Delivery Systems Introduction
11.12.4 Terumo Corporation Revenue in Novel Vaccine Delivery Systems Business (2019-2024)
11.12.5 Terumo Corporation Recent Development
11.13 VAXXAS
11.13.1 VAXXAS Company Detail
11.13.2 VAXXAS Business Overview
11.13.3 VAXXAS Novel Vaccine Delivery Systems Introduction
11.13.4 VAXXAS Revenue in Novel Vaccine Delivery Systems Business (2019-2024)
11.13.5 VAXXAS Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Novel Vaccine Delivery Systems Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Intramuscular Delivery
1.2.3 Intramuscular Delivery
1.2.4 Others
1.3 Market by Application
1.3.1 Global Novel Vaccine Delivery Systems Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals & Clinics
1.3.3 Research Institutes
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Novel Vaccine Delivery Systems Market Perspective (2019-2030)
2.2 Novel Vaccine Delivery Systems Growth Trends by Region
2.2.1 Global Novel Vaccine Delivery Systems Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Novel Vaccine Delivery Systems Historic Market Size by Region (2019-2024)
2.2.3 Novel Vaccine Delivery Systems Forecasted Market Size by Region (2025-2030)
2.3 Novel Vaccine Delivery Systems Market Dynamics
2.3.1 Novel Vaccine Delivery Systems Industry Trends
2.3.2 Novel Vaccine Delivery Systems Market Drivers
2.3.3 Novel Vaccine Delivery Systems Market Challenges
2.3.4 Novel Vaccine Delivery Systems Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Novel Vaccine Delivery Systems Players by Revenue
3.1.1 Global Top Novel Vaccine Delivery Systems Players by Revenue (2019-2024)
3.1.2 Global Novel Vaccine Delivery Systems Revenue Market Share by Players (2019-2024)
3.2 Global Novel Vaccine Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Novel Vaccine Delivery Systems Revenue
3.4 Global Novel Vaccine Delivery Systems Market Concentration Ratio
3.4.1 Global Novel Vaccine Delivery Systems Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Novel Vaccine Delivery Systems Revenue in 2023
3.5 Novel Vaccine Delivery Systems Key Players Head office and Area Served
3.6 Key Players Novel Vaccine Delivery Systems Product Solution and Service
3.7 Date of Enter into Novel Vaccine Delivery Systems Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Novel Vaccine Delivery Systems Breakdown Data by Type
4.1 Global Novel Vaccine Delivery Systems Historic Market Size by Type (2019-2024)
4.2 Global Novel Vaccine Delivery Systems Forecasted Market Size by Type (2025-2030)
5 Novel Vaccine Delivery Systems Breakdown Data by Application
5.1 Global Novel Vaccine Delivery Systems Historic Market Size by Application (2019-2024)
5.2 Global Novel Vaccine Delivery Systems Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Novel Vaccine Delivery Systems Market Size (2019-2030)
6.2 North America Novel Vaccine Delivery Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Novel Vaccine Delivery Systems Market Size by Country (2019-2024)
6.4 North America Novel Vaccine Delivery Systems Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Novel Vaccine Delivery Systems Market Size (2019-2030)
7.2 Europe Novel Vaccine Delivery Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Novel Vaccine Delivery Systems Market Size by Country (2019-2024)
7.4 Europe Novel Vaccine Delivery Systems Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Novel Vaccine Delivery Systems Market Size (2019-2030)
8.2 Asia-Pacific Novel Vaccine Delivery Systems Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Novel Vaccine Delivery Systems Market Size by Region (2019-2024)
8.4 Asia-Pacific Novel Vaccine Delivery Systems Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Novel Vaccine Delivery Systems Market Size (2019-2030)
9.2 Latin America Novel Vaccine Delivery Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Novel Vaccine Delivery Systems Market Size by Country (2019-2024)
9.4 Latin America Novel Vaccine Delivery Systems Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Novel Vaccine Delivery Systems Market Size (2019-2030)
10.2 Middle East & Africa Novel Vaccine Delivery Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Novel Vaccine Delivery Systems Market Size by Country (2019-2024)
10.4 Middle East & Africa Novel Vaccine Delivery Systems Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Altaris Capital Partners
11.1.1 Altaris Capital Partners Company Detail
11.1.2 Altaris Capital Partners Business Overview
11.1.3 Altaris Capital Partners Novel Vaccine Delivery Systems Introduction
11.1.4 Altaris Capital Partners Revenue in Novel Vaccine Delivery Systems Business (2019-2024)
11.1.5 Altaris Capital Partners Recent Development
11.2 Kindeva Drug Delivery
11.2.1 Kindeva Drug Delivery Company Detail
11.2.2 Kindeva Drug Delivery Business Overview
11.2.3 Kindeva Drug Delivery Novel Vaccine Delivery Systems Introduction
11.2.4 Kindeva Drug Delivery Revenue in Novel Vaccine Delivery Systems Business (2019-2024)
11.2.5 Kindeva Drug Delivery Recent Development
11.3 Becton
11.3.1 Becton Company Detail
11.3.2 Becton Business Overview
11.3.3 Becton Novel Vaccine Delivery Systems Introduction
11.3.4 Becton Revenue in Novel Vaccine Delivery Systems Business (2019-2024)
11.3.5 Becton Recent Development
11.4 Dickinson,
11.4.1 Dickinson, Company Detail
11.4.2 Dickinson, Business Overview
11.4.3 Dickinson, Novel Vaccine Delivery Systems Introduction
11.4.4 Dickinson, Revenue in Novel Vaccine Delivery Systems Business (2019-2024)
11.4.5 Dickinson, Recent Development
11.5 Carl Zeiss Foundation
11.5.1 Carl Zeiss Foundation Company Detail
11.5.2 Carl Zeiss Foundation Business Overview
11.5.3 Carl Zeiss Foundation Novel Vaccine Delivery Systems Introduction
11.5.4 Carl Zeiss Foundation Revenue in Novel Vaccine Delivery Systems Business (2019-2024)
11.5.5 Carl Zeiss Foundation Recent Development
11.6 Gerresheimer AG
11.6.1 Gerresheimer AG Company Detail
11.6.2 Gerresheimer AG Business Overview
11.6.3 Gerresheimer AG Novel Vaccine Delivery Systems Introduction
11.6.4 Gerresheimer AG Revenue in Novel Vaccine Delivery Systems Business (2019-2024)
11.6.5 Gerresheimer AG Recent Development
11.7 Corium International
11.7.1 Corium International Company Detail
11.7.2 Corium International Business Overview
11.7.3 Corium International Novel Vaccine Delivery Systems Introduction
11.7.4 Corium International Revenue in Novel Vaccine Delivery Systems Business (2019-2024)
11.7.5 Corium International Recent Development
11.8 Inovio Pharmaceuticals
11.8.1 Inovio Pharmaceuticals Company Detail
11.8.2 Inovio Pharmaceuticals Business Overview
11.8.3 Inovio Pharmaceuticals Novel Vaccine Delivery Systems Introduction
11.8.4 Inovio Pharmaceuticals Revenue in Novel Vaccine Delivery Systems Business (2019-2024)
11.8.5 Inovio Pharmaceuticals Recent Development
11.9 Bioject Medical Technologies
11.9.1 Bioject Medical Technologies Company Detail
11.9.2 Bioject Medical Technologies Business Overview
11.9.3 Bioject Medical Technologies Novel Vaccine Delivery Systems Introduction
11.9.4 Bioject Medical Technologies Revenue in Novel Vaccine Delivery Systems Business (2019-2024)
11.9.5 Bioject Medical Technologies Recent Development
11.10 PharmaJet
11.10.1 PharmaJet Company Detail
11.10.2 PharmaJet Business Overview
11.10.3 PharmaJet Novel Vaccine Delivery Systems Introduction
11.10.4 PharmaJet Revenue in Novel Vaccine Delivery Systems Business (2019-2024)
11.10.5 PharmaJet Recent Development
11.11 Retractable Technologies
11.11.1 Retractable Technologies Company Detail
11.11.2 Retractable Technologies Business Overview
11.11.3 Retractable Technologies Novel Vaccine Delivery Systems Introduction
11.11.4 Retractable Technologies Revenue in Novel Vaccine Delivery Systems Business (2019-2024)
11.11.5 Retractable Technologies Recent Development
11.12 Terumo Corporation
11.12.1 Terumo Corporation Company Detail
11.12.2 Terumo Corporation Business Overview
11.12.3 Terumo Corporation Novel Vaccine Delivery Systems Introduction
11.12.4 Terumo Corporation Revenue in Novel Vaccine Delivery Systems Business (2019-2024)
11.12.5 Terumo Corporation Recent Development
11.13 VAXXAS
11.13.1 VAXXAS Company Detail
11.13.2 VAXXAS Business Overview
11.13.3 VAXXAS Novel Vaccine Delivery Systems Introduction
11.13.4 VAXXAS Revenue in Novel Vaccine Delivery Systems Business (2019-2024)
11.13.5 VAXXAS Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Novel Vaccine Delivery Systems Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Intramuscular Delivery
Table 3. Key Players of Intramuscular Delivery
Table 4. Key Players of Others
Table 5. Global Novel Vaccine Delivery Systems Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Novel Vaccine Delivery Systems Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Novel Vaccine Delivery Systems Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Novel Vaccine Delivery Systems Market Share by Region (2019-2024)
Table 9. Global Novel Vaccine Delivery Systems Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Novel Vaccine Delivery Systems Market Share by Region (2025-2030)
Table 11. Novel Vaccine Delivery Systems Market Trends
Table 12. Novel Vaccine Delivery Systems Market Drivers
Table 13. Novel Vaccine Delivery Systems Market Challenges
Table 14. Novel Vaccine Delivery Systems Market Restraints
Table 15. Global Novel Vaccine Delivery Systems Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Novel Vaccine Delivery Systems Market Share by Players (2019-2024)
Table 17. Global Top Novel Vaccine Delivery Systems Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Novel Vaccine Delivery Systems as of 2023)
Table 18. Ranking of Global Top Novel Vaccine Delivery Systems Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Novel Vaccine Delivery Systems Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Novel Vaccine Delivery Systems Product Solution and Service
Table 22. Date of Enter into Novel Vaccine Delivery Systems Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Novel Vaccine Delivery Systems Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Novel Vaccine Delivery Systems Revenue Market Share by Type (2019-2024)
Table 26. Global Novel Vaccine Delivery Systems Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Novel Vaccine Delivery Systems Revenue Market Share by Type (2025-2030)
Table 28. Global Novel Vaccine Delivery Systems Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Novel Vaccine Delivery Systems Revenue Market Share by Application (2019-2024)
Table 30. Global Novel Vaccine Delivery Systems Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Novel Vaccine Delivery Systems Revenue Market Share by Application (2025-2030)
Table 32. North America Novel Vaccine Delivery Systems Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Novel Vaccine Delivery Systems Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Novel Vaccine Delivery Systems Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Novel Vaccine Delivery Systems Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Novel Vaccine Delivery Systems Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Novel Vaccine Delivery Systems Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Novel Vaccine Delivery Systems Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Novel Vaccine Delivery Systems Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Novel Vaccine Delivery Systems Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Novel Vaccine Delivery Systems Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Novel Vaccine Delivery Systems Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Novel Vaccine Delivery Systems Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Novel Vaccine Delivery Systems Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Novel Vaccine Delivery Systems Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Novel Vaccine Delivery Systems Market Size by Country (2025-2030) & (US$ Million)
Table 47. Altaris Capital Partners Company Detail
Table 48. Altaris Capital Partners Business Overview
Table 49. Altaris Capital Partners Novel Vaccine Delivery Systems Product
Table 50. Altaris Capital Partners Revenue in Novel Vaccine Delivery Systems Business (2019-2024) & (US$ Million)
Table 51. Altaris Capital Partners Recent Development
Table 52. Kindeva Drug Delivery Company Detail
Table 53. Kindeva Drug Delivery Business Overview
Table 54. Kindeva Drug Delivery Novel Vaccine Delivery Systems Product
Table 55. Kindeva Drug Delivery Revenue in Novel Vaccine Delivery Systems Business (2019-2024) & (US$ Million)
Table 56. Kindeva Drug Delivery Recent Development
Table 57. Becton Company Detail
Table 58. Becton Business Overview
Table 59. Becton Novel Vaccine Delivery Systems Product
Table 60. Becton Revenue in Novel Vaccine Delivery Systems Business (2019-2024) & (US$ Million)
Table 61. Becton Recent Development
Table 62. Dickinson, Company Detail
Table 63. Dickinson, Business Overview
Table 64. Dickinson, Novel Vaccine Delivery Systems Product
Table 65. Dickinson, Revenue in Novel Vaccine Delivery Systems Business (2019-2024) & (US$ Million)
Table 66. Dickinson, Recent Development
Table 67. Carl Zeiss Foundation Company Detail
Table 68. Carl Zeiss Foundation Business Overview
Table 69. Carl Zeiss Foundation Novel Vaccine Delivery Systems Product
Table 70. Carl Zeiss Foundation Revenue in Novel Vaccine Delivery Systems Business (2019-2024) & (US$ Million)
Table 71. Carl Zeiss Foundation Recent Development
Table 72. Gerresheimer AG Company Detail
Table 73. Gerresheimer AG Business Overview
Table 74. Gerresheimer AG Novel Vaccine Delivery Systems Product
Table 75. Gerresheimer AG Revenue in Novel Vaccine Delivery Systems Business (2019-2024) & (US$ Million)
Table 76. Gerresheimer AG Recent Development
Table 77. Corium International Company Detail
Table 78. Corium International Business Overview
Table 79. Corium International Novel Vaccine Delivery Systems Product
Table 80. Corium International Revenue in Novel Vaccine Delivery Systems Business (2019-2024) & (US$ Million)
Table 81. Corium International Recent Development
Table 82. Inovio Pharmaceuticals Company Detail
Table 83. Inovio Pharmaceuticals Business Overview
Table 84. Inovio Pharmaceuticals Novel Vaccine Delivery Systems Product
Table 85. Inovio Pharmaceuticals Revenue in Novel Vaccine Delivery Systems Business (2019-2024) & (US$ Million)
Table 86. Inovio Pharmaceuticals Recent Development
Table 87. Bioject Medical Technologies Company Detail
Table 88. Bioject Medical Technologies Business Overview
Table 89. Bioject Medical Technologies Novel Vaccine Delivery Systems Product
Table 90. Bioject Medical Technologies Revenue in Novel Vaccine Delivery Systems Business (2019-2024) & (US$ Million)
Table 91. Bioject Medical Technologies Recent Development
Table 92. PharmaJet Company Detail
Table 93. PharmaJet Business Overview
Table 94. PharmaJet Novel Vaccine Delivery Systems Product
Table 95. PharmaJet Revenue in Novel Vaccine Delivery Systems Business (2019-2024) & (US$ Million)
Table 96. PharmaJet Recent Development
Table 97. Retractable Technologies Company Detail
Table 98. Retractable Technologies Business Overview
Table 99. Retractable Technologies Novel Vaccine Delivery Systems Product
Table 100. Retractable Technologies Revenue in Novel Vaccine Delivery Systems Business (2019-2024) & (US$ Million)
Table 101. Retractable Technologies Recent Development
Table 102. Terumo Corporation Company Detail
Table 103. Terumo Corporation Business Overview
Table 104. Terumo Corporation Novel Vaccine Delivery Systems Product
Table 105. Terumo Corporation Revenue in Novel Vaccine Delivery Systems Business (2019-2024) & (US$ Million)
Table 106. Terumo Corporation Recent Development
Table 107. VAXXAS Company Detail
Table 108. VAXXAS Business Overview
Table 109. VAXXAS Novel Vaccine Delivery Systems Product
Table 110. VAXXAS Revenue in Novel Vaccine Delivery Systems Business (2019-2024) & (US$ Million)
Table 111. VAXXAS Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Novel Vaccine Delivery Systems Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Novel Vaccine Delivery Systems Market Share by Type: 2023 VS 2030
Figure 3. Intramuscular Delivery Features
Figure 4. Intramuscular Delivery Features
Figure 5. Others Features
Figure 6. Global Novel Vaccine Delivery Systems Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Novel Vaccine Delivery Systems Market Share by Application: 2023 VS 2030
Figure 8. Hospitals & Clinics Case Studies
Figure 9. Research Institutes Case Studies
Figure 10. Others Case Studies
Figure 11. Novel Vaccine Delivery Systems Report Years Considered
Figure 12. Global Novel Vaccine Delivery Systems Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Novel Vaccine Delivery Systems Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Novel Vaccine Delivery Systems Market Share by Region: 2023 VS 2030
Figure 15. Global Novel Vaccine Delivery Systems Market Share by Players in 2023
Figure 16. Global Top Novel Vaccine Delivery Systems Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Novel Vaccine Delivery Systems as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Novel Vaccine Delivery Systems Revenue in 2023
Figure 18. North America Novel Vaccine Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Novel Vaccine Delivery Systems Market Share by Country (2019-2030)
Figure 20. United States Novel Vaccine Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Novel Vaccine Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Novel Vaccine Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Novel Vaccine Delivery Systems Market Share by Country (2019-2030)
Figure 24. Germany Novel Vaccine Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Novel Vaccine Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Novel Vaccine Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Novel Vaccine Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Novel Vaccine Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Novel Vaccine Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Novel Vaccine Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Novel Vaccine Delivery Systems Market Share by Region (2019-2030)
Figure 32. China Novel Vaccine Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Novel Vaccine Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Novel Vaccine Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Novel Vaccine Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Novel Vaccine Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Novel Vaccine Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Novel Vaccine Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Novel Vaccine Delivery Systems Market Share by Country (2019-2030)
Figure 40. Mexico Novel Vaccine Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Novel Vaccine Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Novel Vaccine Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Novel Vaccine Delivery Systems Market Share by Country (2019-2030)
Figure 44. Turkey Novel Vaccine Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Novel Vaccine Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Altaris Capital Partners Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2019-2024)
Figure 47. Kindeva Drug Delivery Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2019-2024)
Figure 48. Becton Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2019-2024)
Figure 49. Dickinson, Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2019-2024)
Figure 50. Carl Zeiss Foundation Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2019-2024)
Figure 51. Gerresheimer AG Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2019-2024)
Figure 52. Corium International Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2019-2024)
Figure 53. Inovio Pharmaceuticals Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2019-2024)
Figure 54. Bioject Medical Technologies Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2019-2024)
Figure 55. PharmaJet Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2019-2024)
Figure 56. Retractable Technologies Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2019-2024)
Figure 57. Terumo Corporation Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2019-2024)
Figure 58. VAXXAS Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Novel Vaccine Delivery Systems Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Intramuscular Delivery
Table 3. Key Players of Intramuscular Delivery
Table 4. Key Players of Others
Table 5. Global Novel Vaccine Delivery Systems Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Novel Vaccine Delivery Systems Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Novel Vaccine Delivery Systems Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Novel Vaccine Delivery Systems Market Share by Region (2019-2024)
Table 9. Global Novel Vaccine Delivery Systems Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Novel Vaccine Delivery Systems Market Share by Region (2025-2030)
Table 11. Novel Vaccine Delivery Systems Market Trends
Table 12. Novel Vaccine Delivery Systems Market Drivers
Table 13. Novel Vaccine Delivery Systems Market Challenges
Table 14. Novel Vaccine Delivery Systems Market Restraints
Table 15. Global Novel Vaccine Delivery Systems Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Novel Vaccine Delivery Systems Market Share by Players (2019-2024)
Table 17. Global Top Novel Vaccine Delivery Systems Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Novel Vaccine Delivery Systems as of 2023)
Table 18. Ranking of Global Top Novel Vaccine Delivery Systems Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Novel Vaccine Delivery Systems Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Novel Vaccine Delivery Systems Product Solution and Service
Table 22. Date of Enter into Novel Vaccine Delivery Systems Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Novel Vaccine Delivery Systems Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Novel Vaccine Delivery Systems Revenue Market Share by Type (2019-2024)
Table 26. Global Novel Vaccine Delivery Systems Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Novel Vaccine Delivery Systems Revenue Market Share by Type (2025-2030)
Table 28. Global Novel Vaccine Delivery Systems Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Novel Vaccine Delivery Systems Revenue Market Share by Application (2019-2024)
Table 30. Global Novel Vaccine Delivery Systems Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Novel Vaccine Delivery Systems Revenue Market Share by Application (2025-2030)
Table 32. North America Novel Vaccine Delivery Systems Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Novel Vaccine Delivery Systems Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Novel Vaccine Delivery Systems Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Novel Vaccine Delivery Systems Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Novel Vaccine Delivery Systems Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Novel Vaccine Delivery Systems Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Novel Vaccine Delivery Systems Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Novel Vaccine Delivery Systems Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Novel Vaccine Delivery Systems Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Novel Vaccine Delivery Systems Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Novel Vaccine Delivery Systems Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Novel Vaccine Delivery Systems Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Novel Vaccine Delivery Systems Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Novel Vaccine Delivery Systems Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Novel Vaccine Delivery Systems Market Size by Country (2025-2030) & (US$ Million)
Table 47. Altaris Capital Partners Company Detail
Table 48. Altaris Capital Partners Business Overview
Table 49. Altaris Capital Partners Novel Vaccine Delivery Systems Product
Table 50. Altaris Capital Partners Revenue in Novel Vaccine Delivery Systems Business (2019-2024) & (US$ Million)
Table 51. Altaris Capital Partners Recent Development
Table 52. Kindeva Drug Delivery Company Detail
Table 53. Kindeva Drug Delivery Business Overview
Table 54. Kindeva Drug Delivery Novel Vaccine Delivery Systems Product
Table 55. Kindeva Drug Delivery Revenue in Novel Vaccine Delivery Systems Business (2019-2024) & (US$ Million)
Table 56. Kindeva Drug Delivery Recent Development
Table 57. Becton Company Detail
Table 58. Becton Business Overview
Table 59. Becton Novel Vaccine Delivery Systems Product
Table 60. Becton Revenue in Novel Vaccine Delivery Systems Business (2019-2024) & (US$ Million)
Table 61. Becton Recent Development
Table 62. Dickinson, Company Detail
Table 63. Dickinson, Business Overview
Table 64. Dickinson, Novel Vaccine Delivery Systems Product
Table 65. Dickinson, Revenue in Novel Vaccine Delivery Systems Business (2019-2024) & (US$ Million)
Table 66. Dickinson, Recent Development
Table 67. Carl Zeiss Foundation Company Detail
Table 68. Carl Zeiss Foundation Business Overview
Table 69. Carl Zeiss Foundation Novel Vaccine Delivery Systems Product
Table 70. Carl Zeiss Foundation Revenue in Novel Vaccine Delivery Systems Business (2019-2024) & (US$ Million)
Table 71. Carl Zeiss Foundation Recent Development
Table 72. Gerresheimer AG Company Detail
Table 73. Gerresheimer AG Business Overview
Table 74. Gerresheimer AG Novel Vaccine Delivery Systems Product
Table 75. Gerresheimer AG Revenue in Novel Vaccine Delivery Systems Business (2019-2024) & (US$ Million)
Table 76. Gerresheimer AG Recent Development
Table 77. Corium International Company Detail
Table 78. Corium International Business Overview
Table 79. Corium International Novel Vaccine Delivery Systems Product
Table 80. Corium International Revenue in Novel Vaccine Delivery Systems Business (2019-2024) & (US$ Million)
Table 81. Corium International Recent Development
Table 82. Inovio Pharmaceuticals Company Detail
Table 83. Inovio Pharmaceuticals Business Overview
Table 84. Inovio Pharmaceuticals Novel Vaccine Delivery Systems Product
Table 85. Inovio Pharmaceuticals Revenue in Novel Vaccine Delivery Systems Business (2019-2024) & (US$ Million)
Table 86. Inovio Pharmaceuticals Recent Development
Table 87. Bioject Medical Technologies Company Detail
Table 88. Bioject Medical Technologies Business Overview
Table 89. Bioject Medical Technologies Novel Vaccine Delivery Systems Product
Table 90. Bioject Medical Technologies Revenue in Novel Vaccine Delivery Systems Business (2019-2024) & (US$ Million)
Table 91. Bioject Medical Technologies Recent Development
Table 92. PharmaJet Company Detail
Table 93. PharmaJet Business Overview
Table 94. PharmaJet Novel Vaccine Delivery Systems Product
Table 95. PharmaJet Revenue in Novel Vaccine Delivery Systems Business (2019-2024) & (US$ Million)
Table 96. PharmaJet Recent Development
Table 97. Retractable Technologies Company Detail
Table 98. Retractable Technologies Business Overview
Table 99. Retractable Technologies Novel Vaccine Delivery Systems Product
Table 100. Retractable Technologies Revenue in Novel Vaccine Delivery Systems Business (2019-2024) & (US$ Million)
Table 101. Retractable Technologies Recent Development
Table 102. Terumo Corporation Company Detail
Table 103. Terumo Corporation Business Overview
Table 104. Terumo Corporation Novel Vaccine Delivery Systems Product
Table 105. Terumo Corporation Revenue in Novel Vaccine Delivery Systems Business (2019-2024) & (US$ Million)
Table 106. Terumo Corporation Recent Development
Table 107. VAXXAS Company Detail
Table 108. VAXXAS Business Overview
Table 109. VAXXAS Novel Vaccine Delivery Systems Product
Table 110. VAXXAS Revenue in Novel Vaccine Delivery Systems Business (2019-2024) & (US$ Million)
Table 111. VAXXAS Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Novel Vaccine Delivery Systems Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Novel Vaccine Delivery Systems Market Share by Type: 2023 VS 2030
Figure 3. Intramuscular Delivery Features
Figure 4. Intramuscular Delivery Features
Figure 5. Others Features
Figure 6. Global Novel Vaccine Delivery Systems Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Novel Vaccine Delivery Systems Market Share by Application: 2023 VS 2030
Figure 8. Hospitals & Clinics Case Studies
Figure 9. Research Institutes Case Studies
Figure 10. Others Case Studies
Figure 11. Novel Vaccine Delivery Systems Report Years Considered
Figure 12. Global Novel Vaccine Delivery Systems Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Novel Vaccine Delivery Systems Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Novel Vaccine Delivery Systems Market Share by Region: 2023 VS 2030
Figure 15. Global Novel Vaccine Delivery Systems Market Share by Players in 2023
Figure 16. Global Top Novel Vaccine Delivery Systems Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Novel Vaccine Delivery Systems as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Novel Vaccine Delivery Systems Revenue in 2023
Figure 18. North America Novel Vaccine Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Novel Vaccine Delivery Systems Market Share by Country (2019-2030)
Figure 20. United States Novel Vaccine Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Novel Vaccine Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Novel Vaccine Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Novel Vaccine Delivery Systems Market Share by Country (2019-2030)
Figure 24. Germany Novel Vaccine Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Novel Vaccine Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Novel Vaccine Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Novel Vaccine Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Novel Vaccine Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Novel Vaccine Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Novel Vaccine Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Novel Vaccine Delivery Systems Market Share by Region (2019-2030)
Figure 32. China Novel Vaccine Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Novel Vaccine Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Novel Vaccine Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Novel Vaccine Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Novel Vaccine Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Novel Vaccine Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Novel Vaccine Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Novel Vaccine Delivery Systems Market Share by Country (2019-2030)
Figure 40. Mexico Novel Vaccine Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Novel Vaccine Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Novel Vaccine Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Novel Vaccine Delivery Systems Market Share by Country (2019-2030)
Figure 44. Turkey Novel Vaccine Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Novel Vaccine Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Altaris Capital Partners Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2019-2024)
Figure 47. Kindeva Drug Delivery Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2019-2024)
Figure 48. Becton Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2019-2024)
Figure 49. Dickinson, Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2019-2024)
Figure 50. Carl Zeiss Foundation Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2019-2024)
Figure 51. Gerresheimer AG Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2019-2024)
Figure 52. Corium International Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2019-2024)
Figure 53. Inovio Pharmaceuticals Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2019-2024)
Figure 54. Bioject Medical Technologies Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2019-2024)
Figure 55. PharmaJet Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2019-2024)
Figure 56. Retractable Technologies Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2019-2024)
Figure 57. Terumo Corporation Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2019-2024)
Figure 58. VAXXAS Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Camelina Seeds - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 11, 24
Bentgrass Seeds - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 11, 24
Barley Seeds - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 11, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232